IRIS
OTTANA', Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.104
NA - Nord America 7.961
AS - Asia 3.949
SA - Sud America 1.573
AF - Africa 107
Continente sconosciuto - Info sul continente non disponibili 98
OC - Oceania 7
Totale 21.799
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.783
RU - Federazione Russa 4.048
SG - Singapore 1.692
BR - Brasile 1.344
CN - Cina 1.109
IE - Irlanda 1.051
SE - Svezia 954
HK - Hong Kong 448
DE - Germania 406
IT - Italia 398
UA - Ucraina 395
FR - Francia 222
FI - Finlandia 221
VN - Vietnam 201
GB - Regno Unito 166
IN - India 105
PL - Polonia 79
CA - Canada 73
AR - Argentina 64
BD - Bangladesh 52
IQ - Iraq 43
EC - Ecuador 41
MX - Messico 41
TR - Turchia 36
CO - Colombia 35
JP - Giappone 34
AT - Austria 29
MA - Marocco 28
UZ - Uzbekistan 27
VE - Venezuela 27
PK - Pakistan 26
NL - Olanda 22
ID - Indonesia 21
IR - Iran 21
ZA - Sudafrica 21
IL - Israele 19
BE - Belgio 17
CL - Cile 16
CR - Costa Rica 16
JM - Giamaica 16
CZ - Repubblica Ceca 15
KE - Kenya 15
ES - Italia 14
PY - Paraguay 13
BO - Bolivia 11
KR - Corea 11
UY - Uruguay 11
JO - Giordania 10
MY - Malesia 10
PE - Perù 10
SA - Arabia Saudita 10
AZ - Azerbaigian 9
DZ - Algeria 9
LT - Lituania 8
NP - Nepal 8
RS - Serbia 8
AU - Australia 7
EG - Egitto 7
GR - Grecia 7
PH - Filippine 7
TN - Tunisia 7
CH - Svizzera 6
KZ - Kazakistan 6
LV - Lettonia 6
NO - Norvegia 6
OM - Oman 6
SC - Seychelles 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
NI - Nicaragua 5
PT - Portogallo 5
BG - Bulgaria 4
LB - Libano 4
PR - Porto Rico 4
AL - Albania 3
AM - Armenia 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
GT - Guatemala 3
HR - Croazia 3
LK - Sri Lanka 3
PA - Panama 3
RO - Romania 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
EU - Europa 2
HN - Honduras 2
KW - Kuwait 2
MM - Myanmar 2
PS - Palestinian Territory 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
Totale 21.688
Salva come PNG Salva come JPEG
Città #
Moscow 1.259
Dublin 1.050
Ashburn 981
Singapore 899
Jacksonville 783
Chandler 713
Dallas 706
Nyköping 594
San Jose 447
Hong Kong 446
Dearborn 435
Beijing 378
Council Bluffs 280
The Dalles 191
Princeton 181
Medford 176
Cambridge 173
Los Angeles 158
Lauterbourg 154
Des Moines 98
Boardman 95
Ann Arbor 94
Buffalo 91
Ho Chi Minh City 88
São Paulo 85
Munich 83
New York 72
Warsaw 72
Messina 69
San Mateo 61
Tianjin 56
Jinan 49
Wilmington 48
Belo Horizonte 46
Guangzhou 44
Turku 39
Rio de Janeiro 38
Santa Clara 37
Phoenix 33
Woodbridge 33
Columbus 28
Hanoi 27
Orem 27
Chennai 26
Vienna 26
Curitiba 25
Lancaster 25
Houston 24
Milan 24
Redondo Beach 24
Seattle 24
Shenyang 24
Tokyo 24
Atlanta 23
Haikou 23
Nanjing 23
Brasília 22
Frankfurt am Main 22
Tashkent 22
Shanghai 21
Denver 20
Chicago 19
Salvador 19
Baghdad 18
Brussels 17
Brooklyn 16
Campinas 16
Hebei 16
Montreal 16
St Petersburg 16
Ardabil 15
Rome 15
San Francisco 15
Shenzhen 15
London 14
Washington 14
Johannesburg 13
Ningbo 13
Quito 13
Stockholm 13
Charlotte 12
Fuzhou 12
Naples 12
San José 12
Taiyuan 12
Taizhou 12
Boston 11
Dhaka 11
Düsseldorf 11
Hefei 11
Manchester 11
Mexico City 11
Nanchang 11
Porto Alegre 11
Pune 11
Florence 10
Francofonte 10
Istanbul 10
Kingston 10
Manaus 10
Totale 12.353
Salva come PNG Salva come JPEG
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 262
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 215
Synthesis of tertiary alkyl-substituted acetylenes by electrophilic addition to silylacetylenes 206
9-fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II 203
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 196
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 194
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 193
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 189
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 189
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 184
4-Carbossiamido-9-fluorenoni: proprietà anti-HSV-2 e immunostimolanti 184
3,3'-bi(1,3-thiazolidin-4-one) system. VIII. 3,3'-(1,2-ethanediyl) derivatives and corresponding 1,1'-disulfones: Synthesis, stereochemistry and antiinflammatory activity 184
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 183
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 183
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 183
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 180
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 179
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 178
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 178
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 176
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 175
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 174
2-(4-pyridyl)-Delta(2)-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents .5. 174
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 173
Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures 173
(5-Arylidene-2,4-dioxothiazolidin-3-yl)acetic acids as aldose reductase inhibitors 172
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 171
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 170
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 166
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 164
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 164
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 163
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties 162
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 160
2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone derivatives as aldose reductase inhibitors in the search for drugs to prevent long-term diabetes complications. 159
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents 157
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 157
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 156
AMINOPYRAZINYL DERIVATIVES - SYNTHESIS AND EVALUATION OF ANTIINFLAMMATORY AND RELATED ACTIVITIES 155
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 155
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 154
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 153
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 153
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions 152
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatase inhibitors. 150
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 150
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 150
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 147
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 146
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 146
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 146
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 146
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 145
Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells 144
HALOGENATED ISONIAZID DERIVATIVES .2. UNUSUAL SYNTHESIS OF DELTA(2)-1,3,4-OXADIAZOLINE DERIVATIVES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 142
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 141
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 139
(5-Arylidene-2-thioxo-4-oxothiazolidin-3-yl)acetic acids endowed with chondroprotective and matrix metalloproteinase inhibitory activities 139
An unexpected reaction between 2,3-dihydro-2,2,4-trimethyl-1H-1,5-benzodiazepine and mercaptoacetic acid 138
Electronegativity of zeolites in relation to catalytic activity in the conversion of methanol to hydrocarbons 138
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 137
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 137
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents 135
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 133
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 133
Sintesi di 5-ariliden-2-fenilimino-4-tiazolidinoni attivi come inibitori di protein tirosina fosfatasi. 133
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 132
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 131
EVALUATION OF 4-THIAZOLIDINONE DERIVATIVES AS ALPHA-AMYLASE INHIBITORS 131
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 130
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 129
Azione insulinomimetica di acidi [4-(5-ariliden-2-arilimino-4-ossotiazolidin-3-il)metil]benzoici attivi come inibitori delle fosfatasi PTP1B e LMW-PTP 129
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 128
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 128
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 126
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 124
New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells 122
Progettazione e sintesi di 5-ariliden-4-tiazolidinoni e analoghi come inibitori di protein tirosina fosfatasi 121
Nuovi derivati 5-feniletossibenziliden-4-tiazolidinonici attivi come inibitori della protein tirosina fosfatasi 1B. 121
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 120
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 117
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 116
Utilization of zeolites in agriculture. Part II: Influence in spinach growing. 116
Comparative activity of 5-arylidene-2-thioxo-4-thiazolidinone derivatives in chondrocytes and cartilage: MMP-3 inhibition and determination of GAGs release. 115
Intramolecular cyclization using methyl (bismethylthio)sulfonium salts. Synthesis of functionalized 4,5-dihydro-3,1-benzoxazepines 115
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 114
Non-carboxylic acid 5-arylidene-2,4-thiazolidinedione derivatives as aldose reductase inhibitors 114
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 114
VALUTAZIONE DI COX-2 SELETTIVITÀ SU 3,3'-(1,2-ETANEDIIL)-BIS[2-(3,4-DIMETOSSIFENIL)-4-TIAZOLIDINONI] CHIRALI 113
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 113
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 113
HALOGENATED ISONIAZID DERIVATIVES AS POSSIBLE ANTIMYCOBACTERIAL AND ANTI-HIV AGENTS .3. 112
Sintesi di idrocarburi da metanolo su zeoliti commerciali. Relazione fra attività catalitica e acidità 112
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 111
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 111
Hydrothermal synthesis of zeolites from pumice in alkaline and saline environment 111
Protein-tyrosine phosphatase-1B mediates sleep fragmentation-induced insulin resistance and visceral adipose tissue inflammation in mice 111
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 110
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 110
Valutazione dell'attività antidegenerativa di 2-tiosso-4-tiazolidinoni su colture di condrociti umani 110
Totale 14.896
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.880
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022897 0 0 0 42 61 5 72 43 13 106 168 387
2022/20232.957 234 285 143 263 198 312 68 129 1.219 13 64 29
2023/2024514 37 94 75 41 57 96 7 27 0 15 6 59
2024/20253.128 62 25 52 167 140 71 59 712 838 187 234 581
2025/20269.280 389 677 716 795 655 2.142 1.134 1.121 1.020 331 180 120
2026/20271.431 122 320 472 517 0 0 0 0 0 0 0 0
Totale 21.799